THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
The Tumor Necrosis Factor Receptor (TNFR) is a critical component of the immune system, playing a pivotal role in mediating the effects of the Tumor Necrosis Factor (TNF) family of cytokines. The specific variant, TNFR (22-211 a.a.), is a human recombinant protein that has been extensively studied for its role in various cellular processes, including inflammation, apoptosis, and immune response.
The TNFR (22-211 a.a.) is a recombinant protein produced in Escherichia coli (E. coli). It is a single, non-glycosylated polypeptide chain consisting of 213 amino acids, with a molecular mass of approximately 23.6 kDa . This protein is fused to a 23 amino acid His-tag at the N-terminus, which facilitates its purification through chromatographic techniques .
TNFR1, the receptor for TNF-alpha (TNFSF2) and lymphotoxin-alpha (TNFSF1), is a member of the TNF-receptor superfamily. It is capable of signaling both cell survival and apoptosis, depending on the context of the cellular environment . TNFR1 can activate NF-kappaB, mediate apoptosis, and function as a regulator of inflammation . The receptor’s ability to induce apoptosis requires two sequential signaling complexes, highlighting its complex role in cellular processes .
High levels of soluble TNF receptors, including TNFR1, are found in the amniotic fluid of pregnant women . Germline mutations in the extracellular domains of TNFR1 are linked to autosomal dominant periodic fever syndrome, a condition characterized by recurrent episodes of fever and inflammation . Additionally, defects in the TNFRSF1A gene, which encodes TNFR1, are associated with familial Hibernian fever (FHF) .
The recombinant TNFR (22-211 a.a.) is widely used in research to study the mechanisms of TNF signaling and its implications in various diseases. It serves as a valuable tool for investigating the role of TNF in inflammation, cancer, and autoimmune disorders. Moreover, understanding the interactions between TNFR1 and its ligands can aid in the development of targeted therapies for conditions involving excessive or dysregulated TNF signaling .